Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
about
In vitro selection of Plasmodium falciparum drug-resistant parasite lines.Plasmodium drug targets outside the genetic control of the parasite.Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in NigeriaAntimalarial pharmacology and therapeutics of atovaquoneMolecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapyCytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expressionHDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.Drug-resistant malaria - an insight.Antimalarial drugs: modes of action and mechanisms of parasite resistance.Advances in quantitative structure-activity relationship models of antimalarials.Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era.Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites.In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.Atovaquone tolerance in Plasmodium falciparum parasites selected for high-level resistance to a dihydroorotate dehydrogenase inhibitor.The development of quinoloneesters as novel antimalarial agents targeting the Plasmodium falciparum bc1protein complex
P2860
Q33636206-A4C821EC-B826-434B-B40E-A68096FA6EE8Q34678568-506B2B53-96DC-4438-AD9C-C35CE6C3959EQ34802106-97C3FA80-1425-41A2-B3C9-276043C94298Q35131253-E689A51D-7D6E-4CC2-B442-D735578B610DQ35191258-B35054CA-5F73-437C-B153-B5C9D1A7EF55Q35692516-4E0E5980-D3D4-4904-A41C-B58E11747A34Q35879955-473EBF77-9B9A-4897-91B6-9E5D6CB67DB9Q36086330-65D8C729-00EC-46FC-967A-87E55C62662CQ36933785-03767CA0-9915-4FB5-8FA1-E2379BCAC1D5Q37820670-34F45121-2AD8-4056-A83F-A28300CCD90AQ38029140-B0A082FC-651D-43F7-9B7D-03C6B1D0AEDEQ39306287-B0B3A1BF-62AC-445D-B5E1-5569842E28CFQ41445810-7144628C-0F46-4C4F-8AD1-E93D804BAE25Q42046964-330C6374-9FB8-4333-A238-0B344F028245Q43102405-28C7EC82-7BAC-41C5-8EDC-0B8295615299Q56994500-0132D584-40BB-48DC-9E2C-5C7364116177
P2860
Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@en
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@nl
type
label
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@en
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@nl
prefLabel
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@en
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@nl
P2093
P1476
Prevalence of Plasmodium falci ...... ons for atovaquone resistance.
@en
P2093
Benoit-Vical F
Lelièvre J
Magnaval JF
Senescau A
P304
P356
10.1016/J.TRSTMH.2006.02.004
P577
2006-05-11T00:00:00Z